Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Cenomed announces license deal with ThioPharm
December 2007
SHARING OPTIONS:

IRVINE, Calif.-Cenomed BioSciences LLC, a majority-owned subsidiary of Abraxis BioScience Inc., recently signed an exclusive collaboration and licensing agreement with ThioPharma Inc. to develop and commercialize drug delivery technology, which will be developed for use with certain of Cenomed's psychiatric and neurological disease programs. Under the terms of the agreement, ThioPharma will receive an upfront payment and milestone payments upon achievement of certain development and regulatory events. Cenomed has also agreed to collaborate with ThioPharma as part of the development of the technology.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.